Obstructive hypertrophic cardiomyopathy
Clinical trials for Obstructive hypertrophic cardiomyopathy explained in plain language.
Never miss a new study
Get alerted when new Obstructive hypertrophic cardiomyopathy trials appear
Sign up with your email to follow new studies for Obstructive hypertrophic cardiomyopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a daily pill ease a stiff heart condition?
Disease control OngoingThis trial tests whether an experimental drug called HRS-1893 can improve symptoms and reduce heart-related events in people with obstructive hypertrophic cardiomyopathy, a condition where the heart muscle thickens and blocks blood flow. About 228 adults aged 18 to 85 with modera…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase 3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New heart drug aficamten shows promise for japanese patients with thick heart muscle
Disease control OngoingThis phase 3 trial is testing a drug called aficamten in 36 Japanese adults with symptomatic obstructive hypertrophic cardiomyopathy, a condition where the heart muscle thickens and makes it hard to pump blood. The drug aims to reduce over-contraction of the heart muscle. Researc…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC